Roche to acquire liver drug developer 89bio for up to $3.5 billion
Roche(US:RHHBY) Reutersยท2025-09-18 05:18Roche said on Thursday it agreed to acquire U.S. biotech firm 89bio ETNB.O for up to $3.5 billion to strengthen its development pipeline on liver and cardiometabolic disease treatments. ...